This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's Stop Trading: Buy GW Pharmaceuticals, Not ConAgra Foods

NEW YORK (TheStreet) -- After rallying higher on Tuesday following positive reports about its cannabinoid epilepsy drug, Epidiolex, shares of GW Pharmaceuticals (GWPH) are lower by roughly 5% on Wednesday after the company announced a secondary offering. 

On CNBC's "Cramer's Stop Trading" segment, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said investors want to buy the stock on its secondary offering. 

Why? Well, it's simple. Cramer reasoned that GW Pharmaceuticals is the "only really legitimate" marijuana company for investors to put their money in. The British company is also doing very well, he added. 

However, he did not feel the same toward ConAgra Foods (CAG - Get Report), which reported "a horrible quarter."

According to the CEO, the dividend is still safe, Cramer said. But its private label brands are doing "poorly," consumer volume was weak, and the numbers for Chef Boyardee were "terrible." 

He concluded that canned foods are simply not selling well, because they do not give off the impression of natural and organic food.

-- Written by Bret Kenwell in Petoskey, Mich.

15 Minutes of Every Hour Meeting Are a Waste of Time

Apple Unveils Latest iMac, Starting at $1,099

The U.K. Is 'Pound'-ing the Pavement With Chinese Business Deals

Citigroup Looks Like a Smart Hedge as Interest Rates Remain Low

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
CAG $36.85 -0.43%
GWPH $109.50 1.50%
AAPL $123.89 -1.50%
FB $77.81 0.32%
GOOG $523.88 -1.30%

Markets

DOW 17,791.10 -137.10 -0.76%
S&P 500 2,076.84 -12.62 -0.60%
NASDAQ 4,908.6610 -30.6660 -0.62%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs